Abbott Laboratories Aktie
WKN: 850103 / ISIN: US0028241000
|
16.07.2026 13:34:51
|
Abbott Laboratories Bottom Line Retreats In Q2
(RTTNews) - Abbott Laboratories (ABT) revealed a profit for second quarter that Drops, from the same period last year
The company's earnings totaled $928 million, or $0.53 per share. This compares with $1.779 billion, or $1.01 per share, last year.
Excluding items, Abbott Laboratories reported adjusted earnings of $2.290 billion or $1.31 per share for the period.
The company's revenue for the period rose 13.0% to $12.593 billion from $11.142 billion last year.
Abbott Laboratories earnings at a glance (GAAP) :
-Earnings: $928 Mln. vs. $1.779 Bln. last year. -EPS: $0.53 vs. $1.01 last year. -Revenue: $12.593 Bln vs. $11.142 Bln last year.
-Guidance: Next quarter EPS guidance: $ 1.38 To $ 1.46 Full year EPS guidance: $ 5.45 To $ 5.60
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Abbott Laboratories
Analysen zu Abbott Laboratories
Aktien in diesem Artikel
| Abbott Laboratories | 96,42 | 0,06% |
|